Skip to main content
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. — Investor Relations & Filings

Ticker · PRAX ISIN · US74006W2070 US Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2023-06-14 Director's Dealing
Country US United States of America
Listing US PRAX

About Praxis Precision Medicines, Inc.

https://praxismedicines.com/

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. The company's methodology involves translating insights from genetic epilepsies into treatments for conditions characterized by neuronal excitation-inhibition imbalance. Praxis employs a genetics-focused approach, utilizing translational tools and patient-guided development strategies to advance its portfolio. The developmental pipeline includes several clinical-stage assets and numerous early-stage programs designed to address complex brain disorders.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2023-06-14 English
FORM 4
Director's Dealing
2023-06-14 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 12, 2023, by Praxis Precision Medicines, Inc. The content focuses on the submission of matters to a vote of security holders at the company's 2023 Annual Meeting of Stockholders. It details the voting results for director elections, ratification of the independent auditor, and advisory vote on executive compensation. There is no financial data or comprehensive report content; rather, it is an official announcement of voting results from the annual meeting. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4806 characters, which is consistent with a detailed voting results announcement rather than a full report or proxy statement. Therefore, the correct classification is DVA with high confidence.
2023-06-14 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 9, 2023, by Praxis Precision Medicines, Inc. It reports on "Other Events," specifically the outcomes of an end-of-Phase 2 meeting with the FDA regarding plans for Phase 3 clinical trials. The content focuses on clinical development updates and regulatory planning rather than financial results or management changes. The document is about a specific event disclosure rather than a full financial report, earnings release, or management discussion. Form 8-K filings are generally classified as Regulatory Filings (RNS) when they report material events or other disclosures that do not fit into other specific categories. The document is about a regulatory event and clinical trial update, not a financial report or capital update. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-06-09 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-06-08 English
DEFA14A
Remuneration Information Classification · 95% confidence The document is a Schedule 14A filing, specifically a Proxy Statement Supplement related to the 2023 Annual Meeting of Stockholders of Praxis Precision Medicines, Inc. It includes detailed information about proposals to be voted on, including an advisory (non-binding) vote on executive compensation (Say-on-Pay). The document is not the proxy statement itself but a supplement amending the original proxy materials. It contains detailed voting instructions, board recommendations, and explanations of proposals, which are typical of proxy solicitation materials. The presence of executive compensation discussion and voting proposals confirms it is a proxy solicitation document. Therefore, the correct classification is Remuneration Information (DEF 14A).
2023-06-05 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.